Current and future standards in treatment of myasthenia gravis (Q34014734)

30 July 2017

1 reference

title

Current and future standards in treatment of myasthenia gravis (English)

1 reference

Christiane Schneider-Gold

30 July 2017

0 references

object named as

Christiane Schneider-Gold

series ordinal

2

0 references

Ralf Gold

series ordinal

1

object named as

Ralf Gold

1 reference

30 July 2017

publication date

1 October 2008

1 reference

30 July 2017

number of pages

7

1 reference

inferred from page(s)

published in

Neurotherapeutics

1 reference

30 July 2017

volume

5

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

535-541

1 reference

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

B cell immunobiology in disease: evolving concepts from the clinic

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Corticosteroids for myasthenia gravis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Immunotherapy in autoimmune neuromuscular disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

Intrathymic pathogenesis and dual genetic control of myasthenia gravis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514693

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis

5 July 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

The muddle of mycophenolate mofetil in myasthenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

Mycophenolate mofetil in the therapy of severe myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

Activation and blockade of mouse muscle nicotinic channels by antibodies directed against the binding site of the acetylcholine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

Treatment of Myasthenia Gravis Exacerbation With Intravenous Immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2008.08.011

Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis

21 January 2018

1 reference

12 December 2020

Rituximab in refractory MuSK antibody myasthenia gravis

1 reference

12 December 2020

Effect of immunosuppressive drugs (azathioprine)

1 reference

12 December 2020

Treatment of severe myasthenia gravis with protein A immunoadsorption and cyclophosphamide

1 reference

12 December 2020

Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease

1 reference

12 December 2020

1 reference

12 December 2020

10.1016/J.NURT.2008.08.011

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference